Diethylstilbestrol exposure: Evaluation of the doses received in France

European Journal of Epidemiology

Volumn 27, Issue 4, 2012, Pages 315-318

  Tournaire, Michel ^a   Devouche, Emmanuel ^b   Epelboin, Sylvie ^a   Cabau, Anne ^a  

^a Assistance Publique Hôpitaux de Paris   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DIETHYLSTILBESTROL;

BREAST CANCER; CANCER RISK; DRUG EXPOSURE; DRUG MEGADOSE; FRANCE; HUMAN; LETTER; LOW DRUG DOSE; PREGNANCY OUTCOME; PRESCRIPTION; QUESTIONNAIRE;

EID: 84863716171     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-012-9677-7     Document Type: Letter

References (5)

1. Adami HO, Lagiou P, Trichopoulos D. Breast cancer following diethylstilbestrol exposure in utero: Insights from a tragedy. Eur J Epidemiol. 2012;27:1-3. doi:10.1007/s10654-012-9655-0
2. Palmer JR,Hatch EE, Rosenberg CL,Hartge P,Kaufman RH, Titus-Ernstoff L, et al. Risk of breast cancer in women exposed to diethylstilbestrol in utero: Preliminary results (United States). Cancer Causes Control. 2002; 13:753-8.
3. Palmer JR, Wise LA, Hatch EE, Troisi R, Titus- Ernstoff L, Strohsnitter W, et al. Prenatal diethylstilbestrol exposure and risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2006;15:1509-14.
4. Hoover RN, Hyer M, Pfeiffer RM, Adam E, Bond B, Cheville AL, et al. Adverse health outcomes in women exposed in utero to diethylstilbestrol. N Engl J Med. 2011;365:1304-14.
5. Hill AB. Environment and disease: Association or causation? Proc R Soc Med. 1965;58:295-300.